Title : The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction.

Pub. Date : 2018

PMID : 30443188






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In our study, we evaluated effect of quisinostat alone and in combination with sorafenib in HCC cells via inducing G0/G1 phase arrest through PI3K/AKT/p21 pathway and apoptosis by JNK/c-Jun/caspase3 pathway in vitro and in vivo. Sorafenib AKT serine/threonine kinase 1 Homo sapiens